Targeted-Gene Sequencing and Bioinformatics Analysis of Patients with Pancreatic Mucoepidermoid Carcinoma: A Case Report and Literature Review

References

• Devaraju R, Gantala R, Aitha H, Gotoor SG. Mucoepidermoid carcinoma. BMJ Case Rep. 2014;2014:bcr-2013-202776. doi:10.1136/bcr-2013-202776
   PubMedGoogle Scholar
• Borazanci E, Millis SZ, Korn R, et al. Adenosquamous carcinoma of the pancreas: molecular characterization of 23 patients along with a literature review. World J Gastrointest Oncol. 2015;7(9):132–140. doi:10.4251/wjgo.v7.i9.132
   PubMed Web of Science ®Google Scholar
• Zheng L, Xue J, Jaffee EM, Habtezion A. Role of immune cells and immune-based therapies in pancreatitis and pancreatic ductal adenocarcinoma. Gastroenterology. 2013;144(6):1230–1240. doi:10.1053/j.gastro.2012.12.042
   PubMed Web of Science ®Google Scholar
• Ma R, Yu YQ, Li JT, Peng SY. Mucoepidermoid carcinoma of the pancreas: a case report and a review of literature. J Res Med Sci. 2012;17(9):886–889.
   PubMed Web of Science ®Google Scholar
• Hu HJ, Zhou RX, Liu F, Wang JK, Li FY. You cannot miss it: pancreatic mucoepidermoid carcinoma: a case report and literature review. Medicine (Baltimore). 2018;97(11):e9990. doi:10.1097/MD.0000000000009990
   PubMed Web of Science ®Google Scholar
• Nevala-Plagemann C, Hidalgo M, Garrido-Laguna I. From state-of-the-art treatments to novel therapies for advanced-stage pancreatic cancer. Nat Rev Clin Oncol. 2020;17(2):108–123. doi:10.1038/s41571-019-0281-6
   PubMed Web of Science ®Google Scholar
• Alexandrov LB, Nik-Zainal S, Wedge DC, et al. Signatures of mutational processes in human cancer. Nature. 2013;500(7463):415–421. doi:10.1038/nature12477
   PubMed Web of Science ®Google Scholar
• Frantz V. Atlas of tumor pathology. section VII-Fascicles 27 and 28. Tumors Pancreas. 1959.
   Google Scholar
• Koch KR, Ortmann M, Heindl LM. Conjunctival mucoepidermoid carcinoma. Ophthalmology. 2016;123(3):616. doi:10.1016/j.ophtha.2016.01.016
   PubMed Web of Science ®Google Scholar
• Gieraerts C, Proesmans M, Sauer K, Smet MH, Breysem L. Bronchial mucoepidermoid carcinoma. J Belg Soc Radiol. 2016;100(1):111. doi:10.5334/jbr-btr.1215
   PubMed Web of Science ®Google Scholar
• Roden AC, Erickson-Johnson MR, Yi ES, García JJ. Analysis of MAML2 rearrangement in mucoepidermoid carcinoma of the thymus. Hum Pathol. 2013;44(12):2799–2805. doi:10.1016/j.humpath.2013.07.031
   PubMed Web of Science ®Google Scholar
• Yamamoto M, Hirata K, Tuneyoshi M, et al. Mucoepidermoid carcinoma of the anal canal: a case report and review of the literature. Mol Clin Oncol. 2018;9(5):504–506. doi:10.3892/mco.2018.1706
   PubMed Web of Science ®Google Scholar
• Cipriani NA, Lusardi JJ, McElherne J, et al. Mucoepidermoid carcinoma: a comparison of histologic grading systems and relationship to MAML2 rearrangement and prognosis. Am J Surg Pathol. 2019;43(7):885–897. doi:10.1097/PAS.0000000000001252
   PubMed Web of Science ®Google Scholar
• Pérez-de-oliveira ME, Wagner VP, Araújo ALD, et al. Prognostic value of CRTC1-MAML2 translocation in salivary mucoepidermoid carcinoma: systematic review and meta-analysis. J Oral Pathol Med. 2020;49(5):386–394. doi:10.1111/jop.12970
   PubMed Web of Science ®Google Scholar
• Saeki K, Ohishi Y, Matsuda R, et al. “Pancreatic Mucoepidermoid Carcinoma” Is not a pancreatic counterpart of CRTC1/3-MAML2 fusion gene-related mucoepidermoid carcinoma of the salivary gland, and may more appropriately be termed pancreatic adenosquamous carcinoma with mucoepidermoid carcinoma-like features. Am J Surg Pathol. 2018;42(11):1419–1428. doi:10.1097/PAS.0000000000001135
   PubMed Web of Science ®Google Scholar
• Onoda N, Kang SM, Sugano S, Yamashita Y, Chung YS, Sowa M. Mucoepidermoid carcinoma of the pancreas: report of a case. Surg Today. 1995;25(9):843–847. doi:10.1007/BF00311465
   PubMed Web of Science ®Google Scholar
• Ohtsuki Y, Yoshino T, Takahashi K, Sonobe H, Kohno K, Akagi T. Electron microscopic study of mucoepidermoid carcinoma in the pancreas. Acta Pathol Jpn. 1987;37(7):1175–1182. doi:10.1111/j.1440-1827.1987.tb00435.x
   PubMedGoogle Scholar
• Pandey P, Al-Rohil RN, Goldstein JB, et al. Cutaneous metastasis of a mucoepidermoid carcinoma of the pancreas: first reported case. Am J Dermatopathol. 2016;38(11):852–856. doi:10.1097/DAD.0000000000000604
   PubMed Web of Science ®Google Scholar
• Kitagawa S, Suii H, Miyakawa H. Contrast-enhanced endoscopic ultrasonography features of a mucoepidermoid carcinoma of the pancreas. Endosc Ultrasound. 2018;7(5):351–352. doi:10.4103/eus.eus_25_17
   PubMed Web of Science ®Google Scholar
• Fang Y, Su Z, Xie J, et al. Genomic signatures of pancreatic adenosquamous carcinoma (PASC). J Pathol. 2017;243(2):155–159. doi:10.1002/path.4943
   PubMed Web of Science ®Google Scholar
• Luchini C, Paolino G, Mattiolo P, et al. KRAS wild-type pancreatic ductal adenocarcinoma: molecular pathology and therapeutic opportunities. J Exp Clin Cancer Res. 2020;39(1):227. doi:10.1186/s13046-020-01732-6
   PubMed Web of Science ®Google Scholar
• Selvanathan SP, Graham GT, Grego AR, et al. EWS-FLI1 modulated alternative splicing of ARID1A reveals novel oncogenic function through the BAF complex. Nucleic Acids Res. 2019;47(18):9619–9636. doi:10.1093/nar/gkz699
   PubMed Web of Science ®Google Scholar
• Crona DJ, Skol AD, Leppänen VM, et al. Genetic Variants of VEGFA and FLT4 are determinants of survival in renal cell carcinoma patients treated with sorafenib. Cancer Res. 2019;79(1):231–241. doi:10.1158/0008-5472.CAN-18-1089
   PubMed Web of Science ®Google Scholar
• Mazzio EA, Lewis CA, Elhag R, Soliman KF. Effects of Sepantronium Bromide (YM-155) on the Whole Transcriptome of MDA-MB-231 Cells: highlight on Impaired ATR/ATM Fanconi Anemia DNA Damage Response. Cancer Genomics Proteomics. 2018;15(4):249–264. doi:10.21873/cgp.20083
   PubMed Web of Science ®Google Scholar
• Schawkat K, Manning MA, Glickman JN, Mortele KJ. Pancreatic ductal adenocarcinoma and its variants: pearls and perils. Radiographics. 2020;40(5):1219–1239. doi:10.1148/rg.2020190184
   PubMed Web of Science ®Google Scholar
• Ediriweera MK, Tennekoon KH, Samarakoon SR. Role of the PI3K/AKT/mTOR signaling pathway in ovarian cancer: biological and therapeutic significance. Semin Cancer Biol. 2019;59:147–160. doi:10.1016/j.semcancer.2019.05.012
   PubMed Web of Science ®Google Scholar
• Jia X, Wen Z, Sun Q, et al. Apatinib suppresses the proliferation and apoptosis of gastric cancer Cells via the PI3K/Akt Signaling Pathway. J Buon. 2019;24(5):1985–1991.
   PubMed Web of Science ®Google Scholar
• Dong ZY, Zhong WZ, Zhang XC, et al. Potential predictive value of TP53 and KRAS mutation status for response to PD-1 blockade immunotherapy in lung adenocarcinoma. Clin Cancer Res. 2017;23(12):3012–3024. doi:10.1158/1078-0432.CCR-16-2554
   PubMed Web of Science ®Google Scholar
• Chen N, Fang W, Lin Z, et al. KRAS mutation-induced upregulation of PD-L1 mediates immune escape in human lung adenocarcinoma. Cancer Immunol Immunother. 2017;66(9):1175–1187. doi:10.1007/s00262-017-2005-z
   PubMed Web of Science ®Google Scholar
• Kim JH, Kim HS, Kim BJ. Prognostic value of KRAS mutation in advanced non-small-cell lung cancer treated with immune checkpoint inhibitors: a meta-analysis and review. Oncotarget. 2017;8(29):48248–48252.
   PubMedGoogle Scholar
• Wu Y, Chen W, Xu ZP, Gu W. PD-L1 distribution and perspective for cancer immunotherapy-blockade, knockdown, or inhibition. Front Immunol. 2019;10:2022. doi:10.3389/fimmu.2019.02022
   PubMed Web of Science ®Google Scholar
• Awaya H, Takeshima Y, Yamasaki M, Inai K. Expression of MUC1, MUC2, MUC5AC, and MUC6 in atypical adenomatous hyperplasia, bronchioloalveolar carcinoma, adenocarcinoma with mixed subtypes, and mucinous bronchioloalveolar carcinoma of the lung. Am J Clin Pathol. 2004;121(5):644–653. doi:10.1309/U4WGE9EBFJN6CM8R
   PubMed Web of Science ®Google Scholar
• Chu PG, Weiss LM. Immunohistochemical characterization of signet-ring cell carcinomas of the stomach, breast, and colon. Am J Clin Pathol. 2004;121(6):884–892. doi:10.1309/A09ERYMFR64NERDW
   PubMed Web of Science ®Google Scholar
• Galon J, Pagès F, Marincola FM, et al. The immune score as a new possible approach for the classification of cancer. J Transl Med. 2012;10:1. doi:10.1186/1479-5876-10-1
   PubMed Web of Science ®Google Scholar
• Reichling C, Taieb J, Derangere V, et al. Artificial intelligence-guided tissue analysis combined with immune infiltrate assessment predicts stage III colon cancer outcomes in PETACC08 study. Gut. 2020;69(4):681–690. doi:10.1136/gutjnl-2019-319292
   PubMed Web of Science ®Google Scholar